Alamar Biosciences
Price chart
Anonymous reader poll. Unscientific, not investment advice.
✦ StockVane Quant Insights how this is computed
- Mid-pack momentum — held if you own it, not a fresh buy.
- Signal has read HOLD for 1 year.
- Recent price momentum is -23.6% on average (3-month/1-year).
- Main-fund capital flow has been a net outflow over the last 45 sessions.
- Short interest has risen to 3.2% of float.
- Analyst tilt is Buy.
- Price is below its 20-day average and below its 60-day average.
- The 20-day average is above the 60-day average, a short-term uptrend.
Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.
Performance
Key statistics
Price & volume
- Prev close
- 28.68
- Open
- 28.25
- Day range
- 26.24 - 28.25
- Avg price
- 26.81
- Volume
- 712.60K
- Turnover
- 19.10M
- Turnover ratei
- 1.70%
- Volume ratioi
- 1.23
- Amplitudei
- 7.01%
- 52-week rangei
- 18.85 - 39.61
Valuation
- P/Ei
- -49.04
- P/E (TTM)i
- -23.01
- P/Bi
- 6.06
- EPSi
- -0.54
- Book value / shi
- 4.37
- Net profit
- -37.52M
- Net assets
- 303.70M
Share structure
- Market cap
- 1.84B
- Float capi
- 1.11B
- Shares out
- 69.48M
- Float sharesi
- 41.98M
Dividend & listing
- Div yield (TTM)i
- 0.00%
- Dividend (TTM)
- 0.00
- Listing date
- 2026-04-17
33.1% below the 52-week high
Trading activity
Net capital flow main funds, last 45 sessions
-5.46M net over the window
Short interest
- Shares short
- 2.24M
- % of floati
- 3.23%
- Days to coveri
- 3.27
- As of
- 2026-10-30
Frequently asked questions
What is the current stock price of Alamar Biosciences (ALMR)?
Alamar Biosciences last traded at 26.48. This page shows a periodic quote snapshot. Check the displayed quote time.
What is Alamar Biosciences's market cap?
About 1.84B.
What is the P/E ratio of Alamar Biosciences?
The trailing twelve-month P/E is -23.01. The Valuation tab shows it against the stock's own five-year range.
Does Alamar Biosciences pay a dividend?
Alamar Biosciences does not currently pay a regular dividend.
Is Alamar Biosciences a buy according to analysts?
The consensus of 2 analysts is a Buy rating, with an average 12-month price target of 36.00, which implies 36.0% upside from the current price. This is not investment advice.
What is Alamar Biosciences's StockVane Quant Rating?
The StockVane Momentum strategy currently rates Alamar Biosciences a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.
Quote time 2026-11-20 19:30:06 · For reference only, not investment advice and not tailored to your situation.
Alamar Biosciences discussion 0 comments